Antipodes Partners LTD Quest Diagnostics Inc Transaction History
Antipodes Partners LTD
- $4.06 Billion
- Q3 2025
A detailed history of Antipodes Partners LTD transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Antipodes Partners LTD holds 61,707 shares of DGX stock, worth $8.46 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
61,707
Previous 1,000
6070.7%
Holding current value
$8.46 Million
Previous $137,000
6074.45%
% of portfolio
0.21%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding DGX
# of Institutions
1,130Shares Held
105MCall Options Held
487KPut Options Held
534K-
Vanguard Group Inc Valley Forge, PA14.3MShares$1.95 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY10.1MShares$1.38 Billion0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.01MShares$960 Million0.14% of portfolio
-
State Street Corp Boston, MA5.22MShares$716 Million0.03% of portfolio
-
Jpmorgan Chase & CO New York, NY4.32MShares$592 Million0.04% of portfolio
About QUEST DIAGNOSTICS INC
- Ticker DGX
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 113,887,000
- Market Cap $15.6B
- Description
- Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...